Quantum Genesis AI Corp. (QGAI)

OTCMKTS · Delayed Price · Currency is USD
0.1200
-0.1150 (-48.94%)
At close: Apr 21, 2026
Market Cap4.92M
Revenue (ttm)n/a
Net Income-4.49M
EPS-0.12
Shares Out40.97M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,400
Average Volume3,693
Open0.2500
Previous Close0.2350
Day's Range0.1200 - 0.2500
52-Week Range0.0025 - 5.0400
Beta31.69
RSI39.62
Earnings DateJun 16, 2026

About Quantum Genesis AI

Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. w... [Read more]

Sector Materials
Founded 2015
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol QGAI
Full Company Profile

Financial Performance

Financial Statements